Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $37,971,214 |
| Sells | 155 | $125,498,471 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 8,761 | 27.694 | 242,627 | D |
| 19 Nov 2024 21:57 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Nov 2024 | Sale | 300 | 28.823 | 8,647 | D |
| 08 Nov 2024 17:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 06 Nov 2024 | Sale | 10,000 | 35.189 | 351,890 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 34,943 | 31.254 | 1,092,109 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 15,481 | 32.267 | 499,525 | D |
| 05 Nov 2024 09:04 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Nov 2024 | Sale | 292 | 32.937 | 9,618 | D |
| 05 Nov 2024 09:00 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Nov 2024 | Sale | 81,280 | 31.472 | 2,558,044 | D |
| 05 Nov 2024 09:00 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Nov 2024 | Sale | 27,086 | 32.499 | 880,268 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 30 Oct 2024 | Sale | 4,515 | 32.526 | 146,855 | D |
| 01 Nov 2024 20:59 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 01 Nov 2024 | Sale | 15,485 | 32.619 | 505,105 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 16 Oct 2024 | Sale | 24,992 | 31.136 | 778,151 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 17 Oct 2024 | Sale | 3,103 | 31.118 | 96,559 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 18 Oct 2024 | Sale | 63,313 | 31.527 | 1,996,069 | D |
| 18 Oct 2024 20:57 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 18 Oct 2024 | Sale | 226 | 32.12 | 7,259 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 14 Oct 2024 | Sale | 40,000 | 30.152 | 1,206,080 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 14,525 | 30.496 | 442,954 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 15 Oct 2024 | Sale | 300 | 30.927 | 9,278 | D |
| 16 Oct 2024 20:06 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Oct 2024 | Sale | 6,136 | 30.029 | 184,258 | D |
| 03 Oct 2024 20:09 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Oct 2024 | Sale | 10,000 | 28.177 | 281,770 | D |
| 23 Sep 2024 18:00 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 20 Sep 2024 | Sale | 5,500 | 27.652 | 152,086 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 18 Sep 2024 | Sale | 3,871 | 27.56 | 106,685 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 17 Sep 2024 | Sale | 2,037 | 27.548 | 56,115 | D |
| 18 Sep 2024 21:19 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 16 Sep 2024 | Sale | 2,485 | 27.515 | 68,375 | D |
| 13 Sep 2024 17:16 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 10 Sep 2024 | Sale | 568 | 26.18 | 14,870 | D |
| 13 Sep 2024 17:14 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 10 Sep 2024 | Sale | 637 | 26.18 | 16,677 | D |
| 13 Sep 2024 17:13 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 10 Sep 2024 | Sale | 639 | 26.18 | 16,729 | D |
| 13 Sep 2024 17:11 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 10 Sep 2024 | Sale | 537 | 26.18 | 14,059 | D |
| 13 Sep 2024 17:10 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 10 Sep 2024 | Sale | 1,738 | 26.18 | 45,501 | D |
| 05 Sep 2024 16:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Sep 2024 | Sale | 1,290 | 27.576 | 35,573 | D |
| 05 Sep 2024 16:08 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Sep 2024 | Sale | 3,710 | 26.419 | 98,014 | D |
| 05 Sep 2024 16:05 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 03 Sep 2024 | Sale | 949 | 27.614 | 26,206 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 27 Aug 2024 | Sale | 23,175 | 26.412 | 612,098 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 26 Aug 2024 | Sale | 24,372 | 27.211 | 663,186 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 26 Aug 2024 | Sale | 18,116 | 27.211 | 492,954 | D |
| 29 Aug 2024 16:30 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 26 Aug 2024 | Sale | 32,671 | 27.211 | 889,011 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 26 Aug 2024 | Sale | 5,200 | 27.514 | 143,073 | D |
| 28 Aug 2024 11:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 23 Aug 2024 | Sale | 8,851 | 27.527 | 243,641 | D |
| 02 Aug 2024 21:32 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Aug 2024 | Sale | 1,969 | 27.23 | 53,616 | D |
| 02 Aug 2024 21:32 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Aug 2024 | Sale | 3,031 | 26.44 | 80,140 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 25 Jul 2024 | Sale | 20,481 | 27.658 | 566,463 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 25 Jul 2024 | Sale | 1,791 | 27 | 48,357 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 24 Jul 2024 | Sale | 79,446 | 27.19 | 2,160,137 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 24 Jul 2024 | Sale | 59,637 | 26.71 | 1,592,904 | D |
| 25 Jul 2024 17:54 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 23 Jul 2024 | Sale | 500 | 28.01 | 14,005 | D |
| 18 Jul 2024 21:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 16 Jul 2024 | Sale | 5,008 | 28.045 | 140,449 | D |
| 18 Jul 2024 21:41 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 16 Jul 2024 | Sale | 29,803 | 28.045 | 835,825 | D |
| 02 Jul 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Jul 2024 | Sale | 5,000 | 23.404 | 117,020 | D |
| 13 Jun 2024 18:13 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 11 Jun 2024 | Sale | 2,516 | 22.641 | 56,965 | D |
| 13 Jun 2024 18:11 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 11 Jun 2024 | Sale | 2,825 | 22.641 | 63,961 | D |
| 13 Jun 2024 18:09 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 11 Jun 2024 | Sale | 2,831 | 22.64 | 64,094 | D |
| 13 Jun 2024 18:06 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 11 Jun 2024 | Sale | 2,380 | 22.641 | 53,886 | D |
| 13 Jun 2024 18:04 | AKRO | Akero Therapeutics Inc | LAMY PATRICK | Senior VP, Commercial Strategy | 11 Jun 2024 | Sale | 569 | 22.641 | 12,883 | D |
| 13 Jun 2024 18:01 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 11 Jun 2024 | Sale | 7,894 | 22.641 | 178,728 | D |
| 05 Jun 2024 17:05 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 03 Jun 2024 | Sale | 5,000 | 19.288 | 96,440 | D |
| 02 May 2024 21:07 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 May 2024 | Sale | 5,000 | 20.1499 | 100,750 | D |
| 03 Apr 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Apr 2024 | Sale | 400 | 25.025 | 10,010 | D |
| 03 Apr 2024 18:55 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 01 Apr 2024 | Sale | 4,600 | 24.3267 | 111,903 | D |
| 15 Mar 2024 16:45 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Mar 2024 | Sale | 723 | 28.33 | 20,483 | D |
| 15 Mar 2024 16:44 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Mar 2024 | Sale | 724 | 28.33 | 20,511 | D |
| 15 Mar 2024 16:43 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 13 Mar 2024 | Sale | 1,969 | 28.33 | 55,782 | D |
| 15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Mar 2024 | Sale | 651 | 28.33 | 18,443 | D |
| 15 Mar 2024 16:42 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Mar 2024 | Sale | 619 | 28.33 | 17,536 | D |
| 06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 114 | 36.28 | 4,136 | D |
| 06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 7,995 | 35.4941 | 283,775 | D |
| 06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 9,614 | 33.8326 | 325,267 | D |
| 06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 14,680 | 34.6303 | 508,373 | D |
| 06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 6,770 | 32.2803 | 218,538 | D |
| 06 Mar 2024 20:14 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 04 Mar 2024 | Sale | 35,827 | 31.4002 | 1,124,975 | D |
| 06 Mar 2024 20:13 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 04 Mar 2024 | Sale | 20,646 | 35.49 | 732,727 | D |
| 29 Dec 2023 20:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 27 Dec 2023 | Sale | 5,414 | 24 | 129,936 | D |
| 18 Dec 2023 20:49 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 14 Dec 2023 | Sale | 597 | 20.76 | 12,394 | D |
| 18 Dec 2023 20:40 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 14 Dec 2023 | Sale | 611 | 20.76 | 12,684 | D |
| 18 Dec 2023 20:39 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 14 Dec 2023 | Sale | 543 | 20.76 | 11,273 | D |
| 18 Dec 2023 20:37 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 14 Dec 2023 | Sale | 1,628 | 20.76 | 33,797 | D |
| 18 Dec 2023 20:29 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 14 Dec 2023 | Sale | 514 | 20.76 | 10,671 | D |
| 11 Dec 2023 21:06 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 08 Dec 2023 | Purchase | 50,000 | 19.854 | 992,700 | I |
| 11 Dec 2023 21:06 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 08 Dec 2023 | Purchase | 50,000 | 19.8048 | 990,240 | I |
| 11 Dec 2023 20:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 11 Dec 2023 | Sale | 7,405 | 20.0233 | 148,273 | D |
| 11 Dec 2023 20:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 08 Dec 2023 | Sale | 12,873 | 20.0086 | 257,571 | D |
| 11 Dec 2023 20:59 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 07 Dec 2023 | Sale | 6,700 | 20.0187 | 134,125 | D |
| 05 Dec 2023 08:37 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 01 Dec 2023 | Purchase | 50,000 | 16.9946 | 849,730 | I |
| 05 Dec 2023 08:37 | AKRO | Akero Therapeutics Inc | GRAHAM G. WALMSLEY | Director | 30 Nov 2023 | Purchase | 50,000 | 16.8967 | 844,835 | I |
| 21 Nov 2023 17:30 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 17 Nov 2023 | Sale | 30,000 | 14.6753 | 440,259 | D |
| 04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 6,470 | 50.5619 | 327,135 | D |
| 04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 1,700 | 49.7059 | 84,500 | D |
| 04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 5,300 | 46.8836 | 248,483 | D |
| 04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 2,662 | 48.5632 | 129,275 | D |
| 04 Oct 2023 20:41 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 02 Oct 2023 | Sale | 8,868 | 46.057 | 408,433 | D |
| 04 Oct 2023 20:33 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 02 Oct 2023 | Sale | 490 | 51.1 | 25,039 | D |
| 25 Sep 2023 20:36 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 13 Sep 2023 | Sale | 1,682 | 50.34 | 84,672 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | WHITE WILLIAM RICHARD | Chief Financial Officer | 13 Sep 2023 | Sale | 632 | 50.34 | 31,815 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,200 | 48.3577 | 106,387 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 21 Sep 2023 | Sale | 2,800 | 47.8461 | 133,969 | D |
| 25 Sep 2023 20:31 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 13 Sep 2023 | Sale | 617 | 50.34 | 31,060 | D |
| 25 Sep 2023 20:30 | AKRO | Akero Therapeutics Inc | ROLPH TIMOTHY | Chief Scientific Officer | 13 Sep 2023 | Sale | 531 | 50.34 | 26,731 | D |
| 25 Sep 2023 20:28 | AKRO | Akero Therapeutics Inc | YOUNG JONATHAN | Chief Operating Officer | 13 Sep 2023 | Sale | 562 | 50.34 | 28,291 | D |
| 18 Sep 2023 18:48 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Sep 2023 | Sale | 127 | 50.24 | 6,380 | D |
| 18 Sep 2023 18:48 | AKRO | Akero Therapeutics Inc | CHENG ANDREW | President and CEO | 01 Sep 2023 | Sale | 24,873 | 49.7675 | 1,237,867 | D |
| 30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 500 | 50.67 | 25,335 | D |
| 30 Aug 2023 19:04 | AKRO | Akero Therapeutics Inc | YALE CATRIONA | Chief Development Officer | 28 Aug 2023 | Sale | 5,245 | 49.9248 | 261,856 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)